TPB Stock Forecast & Price Target

Turning Point Brands is positioned favorably because its nicotine pouch and modern oral brands are already outperforming expectations, with scanner data, DTC trends, and retail distribution continuing to strengthen. The company’s growing presence in large chains such as Circle K and 7-Eleven, combined with expansion into smaller retailers where slot fees are lower, should improve market share economics and support a beat-and-raise profile as distribution scales. Financially, the outlook is bolstered by high-single-digit-plus top-line growth, 2026 revenue modeled at about $525 million, 2027 revenue at about $587.5 million, and solid cash flow that can support both balance-sheet strength and shareholder returns.

Turning Point Brands is facing a weaker earnings profile as FY26 EBITDA guidance was narrowed to $70M-$80M from $70M-$90M, reflecting higher freight costs and delays in onshoring that also pushed any domestic production margin benefit to 2027. The negative view is reinforced by execution risk around the CEO transition, continued elevated investment spending, and uncertainty over PMTA approval, which could hinder margin expansion and longer-term production flexibility. Additional pressure comes from a competitive modern oral nicotine market, potential declines in MST and loose-leaf consumption, and the possibility that slotting fees and distribution gains normalize faster than expected.